Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bluejay Diagnostics (BJDX) Other Operating Expenses (2022 - 2023)

Bluejay Diagnostics (BJDX) has disclosed Other Operating Expenses for 2 consecutive years, with $687.0 as the latest value for Q4 2023.

  • Quarterly Other Operating Expenses fell 99.98% to $687.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $283443.0 through Dec 2023, down 95.2% year-over-year, with the annual reading at $8297.0 for FY2024, 97.07% down from the prior year.
  • Other Operating Expenses hit $687.0 in Q4 2023 for Bluejay Diagnostics, up from -$19619.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $4.5 million in Q4 2022 to a low of -$19619.0 in Q3 2023.